The Food and Drug Administration on Monday approved a drug called baricitinib as the first oral tablet for treating severe alopecia areata, an autoimmune disorder affecting more than 300,000 people in the United States every year.
Alopecia areata causes either temporary or permanent patchy hair loss that can affect any hair-bearing site of the body, leading to emotional distress. The condition has come to the fore recently through high-profile cases including Hollywood actress Jada Pinkett Smith and congresswoman Ayanna Pressley.
Baricitinib, which is made by US pharmaceutical company Eli Lilly and known by the trade name Olumiant, belongs to a class of drugs called Janus kinase inhibitors. It works by interfering with the cellular pathway that leads to inflammation.randomized, controlled clinical trialsEach trial split participants into three groups: a placebo group, a group that received a 2-milligram dose every day, and a group that received a 4-milligram dose every day.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Editorial: The FDA is right to ban menthol cigarettesThe FDA plans to ban menthol in cigarettes and cigars, and the L.A. City Council took the ban an important step further. Time to rid the country of this flavoring that lures young smokers.
Consulte Mais informação »
FDA says Pfizer COVID vaccine apparently safe, effective in kids under 5Finding is key step in process that could see vaccinations starting soon for that age group. Evaluation of Moderna's vaccine for the youngest kids is also underway.
Consulte Mais informação »
FDA: Pfizer COVID-19 Shot Appears Effective For Kids Under 5The review by federal health officials was a key step toward a long-awaited decision to begin vaccinating the youngest American children.
Consulte Mais informação »
FDA says Pfizer COVID-19 vaccine appears effective for children under 5The FDA said Pfizer's coronavirus vaccine appears to be safe for children younger than 5, the only age group not yet eligible for vaccination in the U.S.
Consulte Mais informação »
Pfizer COVID vaccines safe and effective for small children, FDA staff sayU.S. Food and Drug Administration staff reviewers on Sunday said Pfizer-BioNTech’s (PFE.N), COVID-19 vaccines were effective and safe for use in children aged 6 months to 4 years.
Consulte Mais informação »
Pfizer COVID shot safe and effective for children under 5, review by FDA scientists findsThe FDA's independent experts are meeting this week to consider emergency use authorization of the vaccine for young children.
Consulte Mais informação »